Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent

Church, 2006, Burn wound infections, Clin Microbiol Rev, 19, 403, 10.1128/CMR.19.2.403-434.2006 de Macedo, 2005, Bacterial and fungal colonization of burn wounds, Mem Inst Oswaldo Cruz, 100, 535, 10.1590/S0074-02762005000500014 Vindenes, 1995, Microbial colonization of large wounds, Burns, 21, 575, 10.1016/0305-4179(95)00047-F Aziz, 2012, A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds, Burns, 38, 307, 10.1016/j.burns.2011.09.020 Nguyen, 2013, Curcumin: a novel treatment for skin-related disorders, J Drugs Dermatol, 12, 1131 Anand, 2008, Curcumin and cancer: an “old-age” disease with an “age-old” solution, Cancer Lett, 267, 133, 10.1016/j.canlet.2008.03.025 Gunes, 2013, Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study, Toxicol Ind Health Sandur, 2007, Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane), Free Radic Biol Med, 43, 568, 10.1016/j.freeradbiomed.2007.05.009 Somparn, 2007, Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives, Biol Pharm Bull, 30, 74, 10.1248/bpb.30.74 Kulac, 2013, The effects of topical treatment with curcumin on burn wound healing in rats, J Mol Histol, 44, 83, 10.1007/s10735-012-9452-9 Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPS J, 15, 195, 10.1208/s12248-012-9432-8 Flora, 2013, Nanocurcumin: a promising therapeutic advancement over native curcumin, Crit Rev Ther Drug Carrier Syst, 30, 331, 10.1615/CritRevTherDrugCarrierSyst.2013007236 Chereddy, 2013, Combined effect of PLGA and curcumin on wound healing activity, J Control Release, 171, 208, 10.1016/j.jconrel.2013.07.015 Bhawana, 2011, Curcumin nanoparticles: preparation, characterization, and antimicrobial study, J Agric Food Chem, 59, 2056, 10.1021/jf104402t Friedman, 2008, Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites, Nitric Oxide, 19, 12, 10.1016/j.niox.2008.04.003 Seleem, 2009, Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens, Antimicrob Agents Chemother, 53, 4270, 10.1128/AAC.00815-09 Gupta, 2008, Bioactive materials for biomedical applications using sol–gel technology, Biomed Mater, 3, 034005, 10.1088/1748-6041/3/3/034005 Yuan, 2012, Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery, Int J Nanomedicine, 7, 5119, 10.2147/IJN.S35575 Martinez, 2009, Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection, J Invest Dermatol, 129, 2463, 10.1038/jid.2009.95 Sanchez, 2014, Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound, Nanomedicine, 10, 269, 10.1016/j.nano.2013.06.002 Han, 2010, Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction, J Sex Med, 7, 224, 10.1111/j.1743-6109.2009.01507.x Nacharaju, 2012, A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response, Nitric Oxide, 27, 150, 10.1016/j.niox.2012.06.003 Han, 2009, Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection, PLoS One, 4, e7804, 10.1371/journal.pone.0007804 Altman, 1993, Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations, Biotechnol Prog, 9, 671, 10.1021/bp00024a017 Truong, 2011, Evaluation of embryotoxicity using the zebrafish model, Methods Mol Biol, 691, 271, 10.1007/978-1-60761-849-2_16 Friedman, 2011, Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology, Virulence, 2, 217, 10.4161/viru.2.3.16161 Verallo-Rowell, 2008, Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis, Dermatitis, 19, 308, 10.2310/6620.2008.08052 Wang, 2009, Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens, Int J Food Microbiol, 136, 71, 10.1016/j.ijfoodmicro.2009.09.001 Mohanty, 2012, Sustained wound healing activity of curcumin loaded oleic acid based polymeric bandage in a rat model, Mol Pharm, 9, 2801, 10.1021/mp300075u Li, 2011, Zebrafish: a model system to study heritable skin diseases, J Invest Dermatol, 131, 565, 10.1038/jid.2010.388 Shehzad, 2013, Molecular mechanisms of curcumin action: signal transduction, Biofactors, 39, 27, 10.1002/biof.1065 Rai, 2008, Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity, Biochem J, 410, 147, 10.1042/BJ20070891 Park, 2005, Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin, J Agric Food Chem, 53, 9005, 10.1021/jf051765z Rudrappa, 2008, Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models, J Agric Food Chem, 56, 1955, 10.1021/jf072591j Sidhu, 1998, Enhancement of wound healing by curcumin in animals, Wound Repair Regen, 6, 167, 10.1046/j.1524-475X.1998.60211.x Mani, 2002, Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing, Biofactors, 16, 29, 10.1002/biof.5520160104 Gopinath, 2004, Dermal wound healing processes with curcumin incorporated collagen films, Biomaterials, 25, 1911, 10.1016/S0142-9612(03)00625-2 Cheppudira, 2013, Curcumin: a novel therapeutic for burn pain and wound healing, Expert Opin Investig Drugs, 22, 1295, 10.1517/13543784.2013.825249 Topman, 2013, The natural medications for wound healing—curcumin, aloe-vera and ginger—do not induce a significant effect on the migration kinematics of cultured fibroblasts, J Biomech, 46, 170, 10.1016/j.jbiomech.2012.09.015 Prow, 2011, Nanoparticles and microparticles for skin drug delivery, Adv Drug Deliv Rev, 63, 470, 10.1016/j.addr.2011.01.012 Samberg, 2010, Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro, Environ Health Perspect, 118, 407, 10.1289/ehp.0901398 Syng-ai, 2004, Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2, Mol Cancer Ther, 3, 1101, 10.1158/1535-7163.1101.3.9 Anitha, 2011, Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles, Carbohydr Polym, 84, 1158, 10.1016/j.carbpol.2011.01.005 Kunwar, 2008, Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells, Biochim Biophys Acta, 1780, 673, 10.1016/j.bbagen.2007.11.016 Sanoj Rejinold, 2011, Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery, Int J Biol Macromol, 49, 161, 10.1016/j.ijbiomac.2011.04.008 Arunraj, 2014, Synthesis, characterization and biological activities of curcumin nanospheres, J Biomed Nanotechnol, 10, 238, 10.1166/jbn.2014.1786 Kumar, 2014, Curcumin loaded poly (2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid—in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells, Eur J Pharm Sci, 51, 34, 10.1016/j.ejps.2013.08.036 Rizzo, 2013, In vivo nanotoxicity testing using the zebrafish embryo assay, J Mater Chem B Mater Biol Med, 1, 3918, 10.1039/c3tb20528b Strahle, 2012, Zebrafish embryos as an alternative to animal experiments—a commentary on the definition of the onset of protected life stages in animal welfare regulations, Reprod Toxicol, 33, 128, 10.1016/j.reprotox.2011.06.121 Irmler, 2004, Developmental variability during early embryonic development of zebra fish, Danio rerio, J Exp Zool B Mol Dev Evol, 302, 446